XML 18 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Shareholders' (Deficit) Equity (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Series C-1 Convertible Preferred Stock
Preferred Stock
Series F Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning Balance at Dec. 31, 2018 $ 35,921 $ 3,906 $ 2,737 $ 3 $ 950,258 $ (160) $ (920,983) $ 160
Beginning Balance (in shares) at Dec. 31, 2018   4 3 26,259        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation expense 6,782       6,782      
Issuance of common stock under ESPP 283       283      
Issuance of common stock under ESPP (in shares)       52        
Issuance of common stock for conversion of Series F Preferred Stock     $ (2,737)   2,737      
Issuance of common stock for conversion of Series F Preferred Stock (in shares)     (3) 782        
Net loss (31,685)           (31,685)  
Ending Balance at Mar. 31, 2019 11,301 $ 3,906   $ 3 959,900   (952,508)  
Ending Balance (in shares) at Mar. 31, 2019   4   27,093        
Beginning Balance at Dec. 31, 2018 35,921 $ 3,906 $ 2,737 $ 3 950,258 $ (160) (920,983) $ 160
Beginning Balance (in shares) at Dec. 31, 2018   4 3 26,259        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (91,275)              
Ending Balance at Sep. 30, 2019 (35,171) $ 3,906   $ 3 973,018   (1,012,098)  
Ending Balance (in shares) at Sep. 30, 2019   4   27,147        
Beginning Balance at Mar. 31, 2019 11,301 $ 3,906   $ 3 959,900   (952,508)  
Beginning Balance (in shares) at Mar. 31, 2019   4   27,093        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation expense 6,321       6,321      
Issuance of common stock under ESPP 201       201      
Issuance of common stock under ESPP (in shares)       32        
Net loss (30,416)           (30,416)  
Ending Balance at Jun. 30, 2019 (12,593) $ 3,906   $ 3 966,422   (982,924)  
Ending Balance (in shares) at Jun. 30, 2019   4   27,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation expense 6,419       6,419      
Issuance of common stock under ESPP 177       177      
Issuance of common stock under ESPP (in shares)       22        
Net loss (29,174)           (29,174)  
Ending Balance at Sep. 30, 2019 (35,171) $ 3,906   $ 3 973,018   (1,012,098)  
Ending Balance (in shares) at Sep. 30, 2019   4   27,147        
Beginning Balance at Dec. 31, 2019 (55,990) $ 3,906   $ 3 977,432   (1,037,331)  
Beginning Balance (in shares) at Dec. 31, 2019   4   27,195        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation expense 2,407       2,407      
Issuance of common stock under 2013 Equity Plan 305       305      
Exercise of stock options for common stock (in shares)       44        
Issuance of common stock under ESPP 200       200      
Issuance of common stock under ESPP (in shares)       38        
Net loss (8,591)           (8,591)  
Ending Balance at Mar. 31, 2020 (61,669) $ 3,906   $ 3 980,344   (1,045,922)  
Ending Balance (in shares) at Mar. 31, 2020   4   27,277        
Beginning Balance at Dec. 31, 2019 $ (55,990) $ 3,906   $ 3 977,432   (1,037,331)  
Beginning Balance (in shares) at Dec. 31, 2019   4   27,195        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of stock options for common stock (in shares) 94,219              
Net loss $ (35,943)              
Ending Balance at Sep. 30, 2020 (85,515) $ 3,906   $ 3 983,850   (1,073,274)  
Ending Balance (in shares) at Sep. 30, 2020   4   27,378        
Beginning Balance at Mar. 31, 2020 (61,669) $ 3,906   $ 3 980,344   (1,045,922)  
Beginning Balance (in shares) at Mar. 31, 2020   4   27,277        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation expense 1,590       1,590      
Issuance of common stock under 2013 Equity Plan 300       300      
Exercise of stock options for common stock (in shares)       50        
Issuance of common stock under ESPP 159       159      
Issuance of common stock under ESPP (in shares)       32        
Net loss (15,592)           (15,592)  
Ending Balance at Jun. 30, 2020 (75,212) $ 3,906   $ 3 982,393   (1,061,514)  
Ending Balance (in shares) at Jun. 30, 2020   4   27,359        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation expense 1,388       1,388      
Issuance of common stock under ESPP 69       69      
Issuance of common stock under ESPP (in shares)       19        
Net loss (11,760)           (11,760)  
Ending Balance at Sep. 30, 2020 $ (85,515) $ 3,906   $ 3 $ 983,850   $ (1,073,274)  
Ending Balance (in shares) at Sep. 30, 2020   4   27,378